Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432445 · ClinicalTrials.gov registry record · Phase 2
Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00432445: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00432445 is a Phase 2 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00432445, a Phase 2 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this trial is to evaluate proton beam radiation therapy as an alternative to external photon beam irradiation in children with retinoblastoma as a means of local tumor control and ocular retention.
Interventions
- RADIATION Proton Beam Radiation Therapy
- PROCEDURE Ophthalmic EUA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-01 |
| Est. Completion | 2014-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00432445
The ClinicalTrials.gov registry entry for NCT00432445 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Proton Beam Radiation Therapy is the first listed.
NCT00432445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00432445 about?
NCT00432445 is a clinical study titled "Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma". The purpose of this trial is to evaluate proton beam radiation therapy as an alternative to external photon beam irradiation in children with retinoblastoma as a means of local tumor control and ocular retention.
What is the current status of trial NCT00432445?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2007-01. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00432445?
The interventions under investigation include: Proton Beam Radiation Therapy (RADIATION), Ophthalmic EUA (PROCEDURE).
Who is sponsoring clinical trial NCT00432445?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.